Your browser doesn't support javascript.
loading
Brigatinib Versus Alectinib in ALK-Positive NSCLC After Disease Progression on Crizotinib: Results of Phase 3 ALTA-3 Trial.
Yang, James Chih-Hsin; Liu, Geoffrey; Lu, Shun; He, Jianxing; Burotto, Mauricio; Ahn, Myung-Ju; Kim, Dong-Wan; Liu, XiaoQing; Zhao, Yanqiu; Vincent, Sylvie; Yin, Jiani; Ma, Xin; Lin, Huamao M; Popat, Sanjay.
Afiliação
  • Yang JC; Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan.
  • Liu G; Department of Medical Oncology, Ontario Cancer Institute, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Lu S; Shanghai Chest Hospital, Shanghai, People's Republic of China.
  • He J; Thoracic Cardio Surgery Department, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.
  • Burotto M; Bradford Hill Clinical Research Center, Santiago, Chile.
  • Ahn MJ; Section of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.
  • Liu X; Fifth Medical Center of PLA General Hospital, Beijing, People's Republic of China.
  • Zhao Y; Affiliated Cancer Hospital of Zhengzhou University, Henan, People's Republic of China.
  • Vincent S; Oncology Cell Therapy Precision and Translational Medicine, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Yin J; Oncology Statistics, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Ma X; Clinical Science, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Lin HM; Global Evidence and Outcomes Oncology, Takeda Development Center Americas, Inc., Lexington, Massachusetts.
  • Popat S; Lung Unit, Royal Marsden Hospital, London, England, United Kingdom. Electronic address: sanjay.popat@rmh.nhs.uk.
J Thorac Oncol ; 18(12): 1743-1755, 2023 12.
Article em En | MEDLINE | ID: mdl-37574132

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Taiwan